Markel Corporation · MKL · FY2026 Q3 · Calendar Q4 2026
Markel posts strong Q3 as underwriting and industrial results improve
Markel’s Q3 supports a constructive operating thesis: underwriting improved, industrial businesses accelerated, investment income benefited from higher rates, and the Enstar transaction reduced legacy reserve uncertainty. The main test is whether these gains remain durable as insurance pricing softens and reserve, property, and industrial-cost risks persist.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about MKL FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, the supplied Q3 analysis shows adjusted operating income at $707 million, a 91.9% combined ratio, stronger industrial performance, and a new Enstar adverse development cover. Share repurchases continued at a higher quarterly level, while the analysis still flags reserve, pricing, and market-softening risks.
Guidance delta
No explicit guidance was provided in the supplied Q3 analysis, so there is no guidance change to report.
Key takeaways
- Adjusted operating income rose 14% to $707 million.
- Insurance premiums grew 9% and the combined ratio improved to 91.9%.
- Industrial revenue rose 13% and operating income increased 29%, led by precast concrete and fire-safety businesses.
- Net investment income benefited from higher rates, while share repurchases totaled $315 million in the quarter.
- The Enstar adverse development cover transferred $2.25 billion of reserves and provided $1.2 billion of protection.
Management priorities
- Continue the share repurchase program.
- Invest in core systems, data analytics, and AI capabilities.
- Pursue selective bolt-on acquisitions.
- Use the industrial backlog to pursue data-center and infrastructure demand.
- Develop insurance-linked securities solutions.
Follow MKL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Apr 30, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Feb 7, 2025 |
| TD Cowen | Hold | Buy | Downgrade | Dec 2, 2024 |
| Jefferies | Hold | Hold | Maintain | Oct 9, 2024 |
| Citigroup | Sell | Sell | Maintain | Jul 23, 2024 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Mar 15, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Feb 4, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Jul 30, 2020 |
| William Blair | Market Perform | Outperform | Downgrade | Nov 17, 2016 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | May 7, 2015 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Nov 10, 2014 |
| Bank of America | Underperform | Underperform | Maintain | May 1, 2013 |
| B of A Securities | Underperform | Underperform | Maintain | May 1, 2013 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Dec 20, 2012 |
| Stifel | Hold | Buy | Downgrade | Dec 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $1,874.55. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Mark Hughes | $1,950 | $1,759.21 | +4.0% | Apr 30, 2026 |
| Truist Financial | Mark Hughes | $2,100 | $2,127.72 | +12.0% | Feb 6, 2026 |
| RBC Capital | Scott Heleniak | $1,625 | $1,576.55 | -13.3% | May 3, 2024 |
| Janney Montgomery | Analyst unavailable | $1,550 | $1,280.74 | -17.3% | Dec 22, 2022 |
| Truist Financial | Analyst unavailable | $1,500 | $1,384.7 | -20.0% | Apr 28, 2022 |
| RBC Capital | Analyst unavailable | $1,650 | $1,381.53 | -12.0% | Apr 28, 2022 |
Track every rating change on MKL the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMarkel Corporation operates as a multifaceted financial conglomerate, engaging in the marketing and underwriting of specialized insurance offerings across numerous global regions. Its operational footprint spans the United States, Bermuda, the United Kingdom, continental Europe, Canada, the Asia Pacific, and the Middle East. Within its Insurance segment, the company delivers a broad spectrum of protection. This includes general and professional liability coverage, personal lines, marine and energy policies, bespoke specialty programs, and workers' compensation. Furthermore, it provides property insurance encompassing fire, allied perils, and other tailored property coverages, notably safeguarding against catastrophe-exposed risks such as earthquakes and severe wind events. This segment also extends to credit and surety offerings, alongside collateral protection insurance. The Reinsurance division focuses on sophisticated risk transfer solutions.…
Financial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| EG Everest Group, Ltd. | FY2026 Q3 · Calendar Q4 2026 | -18.8% | +3.5% | Everest pairs strong earnings with heavier reserve protection |
| MA Mastercard Incorporated | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +4.2% | Mastercard Q3 growth accelerates as services and digital payments expand |
| OWL Blue Owl Capital Inc. | FY2026 Q3 · Calendar Q4 2026 | +6.6% | +7.7% | Blue Owl reports strong Q3 growth as fundraising and fee income rise |
| KB KB Financial Group Inc. | FY2026 Q3 · Calendar Q4 2026 | +3.6% | -0.7% | KB Financial: profit growth offsets margin and regulatory risks |
| ARES Ares Management Corporation | FY2026 Q3 · Calendar Q4 2026 | +0.8% | +2.9% | Ares Q3: AUM growth and fundraising support a constructive outlook |
| WTW Willis Towers Watson Public Limited Company | FY2026 Q3 · Calendar Q4 2026 | +1.1% | -0.3% | WTW posts solid Q3 growth but lowers full-year outlook |
Latest beats and misses
Who reports nextBeat on EPS
- DXCMFY2026 Q3 · October 29, 2026+8.1% EPS+5.6% move
- ALNYFY2026 Q3 · October 29, 2026+879.5% EPS-25.1% move
- KIMFY2026 Q3 · October 29, 2026+101.6% EPS+4.4% move
- FTIFY2026 Q3 · October 29, 2026+19.9% EPS-6.2% move
- CARRFY2026 Q3 · October 29, 2026+14.8% EPS-1.3% move
- MAFY2026 Q3 · October 29, 2026+2.7% EPS+4.2% move
Missed on EPS
- DLR-PJFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLRFY2026 Q3 · October 29, 2026-8.4% EPS-3.0% move
- EGFY2026 Q3 · October 28, 2026-18.8% EPS+3.5% move
- KYMRFY2026 Q3 · October 29, 2026-4.8% EPS+0.1% move
- DHIFY2026 Q4 · October 29, 2026-11.3% EPS+2.5% move
- BBVAFY2026 Q3 · October 29, 2026-1.6% EPS-2.2% move
Get the MKL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-29T17:11:09.720864+00:00
- FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
- Polygon adjusted daily market bars · 2026-10-30T12:50:43.119424+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T12:50:43.116729+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.